Sphera Funds Management’s VistaGen Therapeutics VTGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-447,939	Closed	-$896K	–	141
2025 Q2	$896K	Sell	447,939 -342,611	-43%	-$778K	0.23%	91
2025 Q1	$1.98M	Sell	790,550 -18,000	-2%	-$50.9K	0.49%	68
2024 Q4	$2.39M	Hold	808,550	–	–	0.44%	74
2024 Q3	$2.43M	Hold	808,550	–	–	0.4%	73
2024 Q2	$2.81M	Hold	808,550	–	–	0.46%	71
2024 Q1	$4.27M	Hold	808,550	–	–	0.69%	54
2023 Q4	$4.16M	Buy	808,550 +708,550	+709%	+$2.68M	0.77%	56
2023 Q3	$524K	Buy	+100,000	New	+$444K	0.13%	80
2022 Q3	–	Sell	-109,705	Closed	-$2.9M	–	90
2022 Q2	$2.9M	Sell	109,705 -55,342	-34%	-$1.95M	0.55%	33
2022 Q1	$6.14M	Buy	165,047 +30,882	+23%	+$1.35M	1.03%	33
2021 Q4	$7.85M	Buy	134,165 +6,667	+5%	+$434K	0.93%	39
2021 Q3	$10.5M	Sell	127,498 -8,524	-6%	-$741K	1.04%	34
2021 Q2	$12.9M	Sell	136,022 -3,217	-2%	-$238K	1.17%	31
2021 Q1	$8.9M	Buy	139,239 +48,406	+53%	+$3.23M	0.82%	35
2020 Q4	$5.29M	Buy	+90,833	New	+$2.32M	0.55%	65
2019 Q3	–	Sell	-22,454	Closed	-$489K	–	102
2019 Q2	$489K	Sell	22,454 -44,948	-67%	-$1.19M	0.07%	83
2019 Q1	$2.59M	Buy	67,402 +18,271	+37%	+$797K	0.35%	83
2018 Q4	$2.21M	Sell	49,131 -6,666	-12%	-$363K	0.32%	71
2018 Q3	$2.43M	Buy	55,797 +10,067	+22%	+$408K	0.32%	81
2018 Q2	$1.88M	Buy	45,730 +4,155	+10%	+$144K	0.3%	84
2018 Q1	$1.16M	Hold	41,575	–	–	0.2%	81
2017 Q4	$1.38M	Buy	41,575 +6,295	+18%	+$208K	0.22%	107
2017 Q3	$1.69M	Buy	35,280 +17,143	+95%	+$903K	0.3%	91
2017 Q2	$1.02M	Hold	18,137	–	–	0.21%	105
2017 Q1	$1.07M	Hold	18,137	–	–	0.27%	92
2016 Q4	$2.03M	Hold	18,137	–	–	0.62%	56
2016 Q3	$2.26M	Buy	18,137 +8,334	+85%	+$905K	0.52%	68
2016 Q2	$1.15M	Buy	+9,803	New	+$1.12M	0.32%	75

Other funds holding VTGN